Skin Squamous Cell Carcinoma In Situ
NCI Definition: Intraepidermal squamous cell carcinoma, confined to the epidermis. There is no evidence of invasion. 
There is 1 clinical trial for skin squamous cell carcinoma in situ, of which 0 are open and 1 is completed or closed. Of the trial that contains skin squamous cell carcinoma in situ as an inclusion criterion, 1 is phase 1/phase 2 (0 open).
Cotsiranib is the most common intervention in skin squamous cell carcinoma in situ clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.